Realtime PCR has established itself as a valuable tool used for diagnostics of various diseases such as cancer and infectious diseases and for the detection of bacterial, fungal and viral pathogens. The introduction of novel technology platforms such as digital PCR, HT platforms and improvements in automation and standardization presents novel opportunities for the pharmaceutical industry and the medical community to move the application of qPCR to the next level.